Join
Live feed
·
INSIDERFilingvia Quantisnow
Channel Therapeutics Corporation logo

Friedberg Ezra M bought $100,002 worth of shares (16,667 units at $6.00), increasing direct ownership by 3% to 545,721 units (SEC Form 4) (Amendment)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CHRO (Channel Therapeutics Corporation) and more on Quantisnow.